ESPN analyst Ben Solak agrees that Burden has been worth it, naming the 39th overall pick to his first-team all-rookie team ...
Shares of Ultragenyx Pharmaceutical RARE were up 15.5% yesterday following the completion of the rolling submission of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback